Research, biostatistics and molecular biology of breast cancer

CERTIFICATION

Molecular Biology Course in the context of the Master in Senology and Breast Pathology at the University of Barcelona.

TARGET

Gynecologists, surgeons, pathologists, radiologists and oncologists (specialists).

DIRECTION

Director: Aleix Prat Aparicio.

DURATION

del 9 Noviembre de 2020 al 15 Enero del 2021

CREDITS

10 ECTS

FORMAT

Online

The Course is consists of 10 ECTS credits (1ECST = 25 teaching hours) and takes place at the Universidad de Barcelona. It is aimed at specialists who already have experience in Breast Pathology. It is linked to the second year of the Master in Senology from the same university and is offered virtually.

The objectives of the course are:

  • Clarify the biological basis of breast cancer.
  • Obtain extensive knowledge in immunology.
  • Acquire basic concepts of mutational processes.

The course consists of a total of 10 ECTS credits (1ECST = 25 teaching hours).

José Manuel Pérez García

Head of Service and Director of the Clinical Trials Unity of IOB Instituto de Oncología / Medical Expert in MedSir

Médico especialista en Farmacología Clínica. Cuenta con un máster en Bioética y Derecho y es Miembro del Comité de Ética de Investigación con medicamentos (CEIm) del Hospital Vall d’Hebrón de Barcelona.

Ana Janic

Group Leader at Universidad Pompeu Fabra

Graduated from the University of Belgrade and PhD in Biomedicine from IRB-Barcelona. She is currently Professor Tenure-Track at the Universidad Pompeu Fabra of Barcelona, where she studies how tumor suppressors protect us from the development of cancer.

Atanasio Pandiella

Professor of Research at the Centro de Investigación del Cáncer of Salamanca.

His training includes research at the CNR, Ospedale San Raffaele in Milán and the Memorial Sloan Kettering Cancer Center in New York. His research focuses on the functional characterization of molecules involved in different human solid tumors, in particular breast tumors.

Aranzazu Fernández Martínez

Medical Oncologist

Post-doctoral research associate in the laboratory run by Charles M.Perou at the UNC Lineberg Comprehensive Cancer Center. Her research interest is focused on Breast Cancer Genomic Biomarkers.

Dolors Soy Mujer

Head of Pharmacy at Hospital Clínic

PhD in Pharmacy from the Universidad de Barcelona and specialist in Hospital Pharmacy. She is an associate professor at the Faculty of Pharmacy of the Universidad de Barcelona while continuing her research. Her main lines of research focus on knowledge of the dose-concentration-effect relationships of drugs.

Violeta Serra

Group Leader of the VHIO Experimental Therapies Group

PhD from the University of Newcastle and postdoctoral stays in Charité, Berulon and CNIO. She is currently the principal investigator of the VHIO Experimental Therapies Group, where she studies the identification of biomarkers response to targeted therapies in breast cancer.

Claudia Arnedo

PhD student at the Biomedical Genomics laboratory (IRB)

Graduated in Biomedical Sciences from the Universidad de Barcelona. In 2018, she obtained a Master's degree in Bioinformatics for Health Sciences from the Universidad Pompeu Fabra. She is currently carrying out her doctoral thesis in the Biomedical Genomics laboratory (IRB), led by Dr. Núria López Bigas, studying cancer driver mutations.

Justin Odegaard

Vice President of clinical development and laboratory director at Guardant Health

PhD in Biology, physician at the Clinical and Molecular Genetics Area of the Hospital Universitario Vall d’Hebron and Senior Researcher of the Hereditary Cancer Group of the Vall d’Hebron Instituto Oncológico (VHIO).

Toni Hurtado

Dr. Odegaard's specific area of expertise is the detection and characterization of solid tumors using cell-free DNA. In 2016, joined Guardant Health. Dr. Odegaard also maintains an affiliation with Stanford University, where he is a member of the Adjunct Clinical Faculty.

José Rios

Specialist physician in the Department of Pathological Anatomy of the Hospital Clínic

Specialist physician in the Department of Pathological Anatomy of the Hospital Clínic de Barcelona, where she develops healthcare activity in molecular diagnosis and clinical research in patients with solid tumors since 2017. Collaborating professor at the Universidad de Barcelona (Department of Medicine).

Crisitina Teixidó

Group Leader at IBIDELL

Researcher of recognized international prestige with extensive knowledge and experience in basic and translational research of murine models of cancer and tumor angiogenesis. His scientific studies have been published in highly regarded journals in the cancer field.

Ferran Torres

Researcher at the Biosciences Department, Faculty of Medicine (University of Barcelona)

PhD at the Vall d’Hebron Institut de Recerca In late 2011, he became a group leader at the Norwegian Center for Molecular Medicine. He recently joined the Department of Biosciences at the Faculty of Medicine (Universidad de Barcelona), where he has focused on investigating the mechanisms related to the response to anti-ER drugs in breast tumors growth.

Javier Cortés

Coordinator of the Medical Statistics Platform of IDIBAPS-Hospital Clínic of Barcelona.

More than 25 years of experience in statistical-methodological support with more than 200 indexed papers. He currently coordinates the medical statistical platform of IDIBAPS-Hospital Clínic and is an associate professor at the Faculty of Medicine of the UAB. He also collaborates with independent research groups like SOLTI.

Judith Balmaña

Specialist physician in the Department of Pathological Anatomy of the Hospital Clínic

Specialist physician in the Department of Pathological Anatomy of the Hospital Clínic de Barcelona, where she develops healthcare activity in molecular diagnosis and clinical research in patients with solid tumors since 2017. Collaborating professor at the Universidad de Barcelona (Department of Medicine).

Karim Lekadir

Teacher

Médico especializado en farmacología clínica, con cerca de 30 años de experiencia en el diseño y análisis de estudios clínicos. Jefe del centro de Estadística Médica, IDIBAPS-Hospital Clinic Barcelona, y profesor asociado en la Unidad de Bioestadística de la Universidad Autónoma de Barcelona. Consultor médico y estadístico de la Agencia Española de Medicamentos y miembro del CAMH del CatSalut.

Laura Soucek

Teacher

Licenciada en Medicina por la Universidad Autónoma de Barcelona. Especialista en Farmacología Clínica, formada en el Hospital de la Vall d'Hebron. Realizó varios cursos de doctorado del programa de Farmacología. En el año 2007 empezó a trabajar en Bayer como técnico de Farmacovigilancia. Actualmente es la Responsable de Farmacovigilancia para todos los productos de Bayer.

Manel Esteller

Teacher

Investigadora Senior en el IDIBELL y CIBEREHD y profesora asociada en la Universidad de Barcelona. Dirige un grupo de investigación en TGF-beta y Cáncer. Su trabajo en los últimos años se ha centrado en el papel del TGF-beta en fibrosis y cáncer hepáticos, con un particular interés en la relación entre las vías del TGF-beta y del EGFR y el papel de la NADPH oxidasa NOX4 en esos procesos.

Marcos Malumbres

Teacher

Doctor en Oncología Médica por la Universidad de Navarra. Jefe del Programa de Cáncer de Mama, IOB Insititute of Oncology, Madrid y Barcelona. Investigador clínico en el Programa de Investigación del Cáncer de Mama del Instituto de Oncología Vall d’Hebron, centrando su actividad en medicamentos dirigidos contra objetivos moleculares y nuevos agentes de quimioterapia.

Maurizio Scaltriti

Teacher

Doctora especializada como oncóloga médica. Jefa del Grupo de Genética de Cáncer Hereditario en el Servicio de Oncología Médica del Hospital Vall d’Hebron y en VHIO. Su carrera profesional está centrada en la identificación y manejo médico de personas con susceptibilidad genética germinal al cáncer, así como al tratamiento de pacientes con cáncer de mama, especialmente aquellas con una alteración genética hereditaria.

Oscar Salamanca

Teacher

Investigador en el Hospital Universitario Ramón y Cajal y director del Laboratorio de Inteligencia Artificial en Medicina de la Universitat de Barcelona, Su investigación se centra en el desarrollo de enfoques de ciencia de datos y aprendizaje automático para el análisis de datos biomédicos a gran escala. Coordinador de los proyectos euCanSHare y EarlyCayse H2020. Editor asociado de IEEE Transactions on Medical Imaging.

Patricia Villagrasa

Teacher

Graduada en Ciencias Biológicas en la Universidad La Sapienza, Roma, y Doctorado en Genética y Biología Molecular. Dirige el Laboratorio de Modelos de Ratones de Terapias contra el Cáncer en el Instituto de Oncología Vall d'Hebron, en Barcelona, España. Es ICREA Research Profesor y Profesor Asociado en la Universidad Autónoma de Barcelona. Investigación especializada en estrategias de inhibición de Myc.

Ramon Estiarte

Teacher

PhD of Medicine and Surgery from the Universidad de Barcelona. He is currently Director of the Instituto de Investigación contra la Leucemia Josep Carreras (IJC), research professor at ICREA and Tenured Full Professor of genetics at the School of Medicine of the Universidad de Barcelona. Author of more than 500 scientific publications and awarded among others with the Severo Ochoa Award and the Genetics and Oncology National Awards. His research focuses on the epigenetic mechanisms responsible for human disease, mainly cancer.

Sherene Loi

Teacher

Licenciado en Ciencias Biológicas por la Universidad de Navarra y doctorado por la Universidad de León. Después de una estancia posdoctoral en el New York University Medical Center, se incorporó al Centro Nacional de Investigaciones Oncológicas donde es Jefe del Grupo de División Celular y Cáncer. Sus intereses científicos se centran en el estudio del ciclo de división celular y su aplicación en las terapias contra el cáncer.

Teacher

Profesor asociado en el Memorial Sloan Kettering Cancer Center, con más de 15 años de experiencia en terapia dirigida en cáncer de mama. Dirige un laboratorio que trabaja de forma consecutiva con los médicos del Servicio de Desarrollo Temprano de Medicamentos para la dentificación de nuevos mecanismos de resistencia a la terapia dirigida.

Teacher

Pharmacist and MBA from the Instituto de Empresa. With more than 25 years of experience in the drug research and development sector and with extensive management experience in the field of clinical research in CROs (Contract Research Organizations) and in the Oncology area. He is currently Managing Director of APICES (European CRO).

Teacher

PhD in Molecular Biology and Biochemistry from the Universidad Autónoma de Barcelona. After more than 10 years in cancer research, she joined SOLTI in 2013 after a postdoctoral period at Columbia University (New York, USA) focused on breast cancer. Currently, she is the Scientific Director of the Grupo Académico de Investigación Clínica y Traslacional en Cáncer SOLTI, where she coordinates all operations and the scientific team, which supports the design and management of clinical trials for all researchers in the group.

Teacher

Licenciado en Medicina y Cirugía, Doctor en Medicina Preventiva y Salud Pública, Especialista en Medicina del Trabajo, MBA y Programas de Perfeccionamiento Directivo por el IMD, con postgrados en Metodología de Investigación clínica, Epidemiologia, Bioestadística y Medicina de la Industria Farmacéutica. Más de 25 años de experiencia directiva en diversas compañías farmacéuticas. Actualmente es CEO del Grupo académico SOLTI.

Teacher

Oncóloga médica. Investigadora traslacional independiente, que lidera su propio grupo de investigación de laboratorio. Especializada en el tratamiento de pacientes con cáncer de mama, se enfoca en la interacción entre el genoma del cáncer de seno y el paisaje. Miembro del comité asesor científico del grupo cooperativo Australiano de Nueva Zelanda de Ensayos de Cáncer de Mama. Copresidente del Comité Ejecutivo Científico y del Grupo de Trabajo Traslacional del Grupo Internacional de Estudios sobre el Cáncer de Mama.

Aleix Prat Aparicio

Master in Breast Pathology and Breast Cancer co-director.

Bachelor of Medicine from the University of Barcelona PhD from the Universidad Autónoma de Barcelona. Master in Molecular Oncology at the Centro Nacional de Investigaciones Oncológicas (CNIO). PostDoctoral fellowship at the University of North Carolina, USA.

Dr. Miguel Prats de Puig

Master in Breast Pathology and Breast Cancer co-director.

Renowned gynecologist specialist with extensive experience in senology- breast pathology. He has completed training stays in highly prestigious breast pathology units, both nationally and internationally. He has extensive surgical training in benign and malignant processes of the breast, including techniques as selective biopsy of the sentinel lymph node and intraoperative breast ultrasound. He is a pioneer and a reference in Spain in breast surgery with intraoperative radiation therapy. In addition to clinical practice, he also teaches at different universities and is the author of various chapters in books on breast pathology. Furthermore, he is a member of the main medical societies of his specialty at an international level.

Master in Breast Pathology and Breast Cancer co-director.

MORE INFORMATION ADMISSION